These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11758234)

  • 21. The coxibs, selective inhibitors of cyclooxygenase-2.
    Killen JP
    N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
    [No Abstract]   [Full Text] [Related]  

  • 22. The cox-2 inhibitors.
    Strassels S
    J Mass Dent Soc; 1999; 48(3):43-4. PubMed ID: 10808349
    [No Abstract]   [Full Text] [Related]  

  • 23. New versus old drugs for arthritis.
    Health News; 1999 Nov; 5(14):7. PubMed ID: 10624169
    [No Abstract]   [Full Text] [Related]  

  • 24. COX-2 inhibitors: cancer prevention or cardiovascular risk?
    Senior K
    Lancet Oncol; 2005 Feb; 6(2):68. PubMed ID: 15704289
    [No Abstract]   [Full Text] [Related]  

  • 25. COX-2 inhibitors: better than ibuprofen for dental pain?
    Dionne R
    Compend Contin Educ Dent; 1999 Jun; 20(6):518-20, 522-4. PubMed ID: 10650365
    [No Abstract]   [Full Text] [Related]  

  • 26. Coxibs and cardiovascular disease.
    Fitzgerald GA
    N Engl J Med; 2004 Oct; 351(17):1709-11. PubMed ID: 15470192
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rapid, strong and long-term effectiveness. Coxib also effective in toothache].
    MMW Fortschr Med; 2003 Jan; 145(1-2):53. PubMed ID: 12638443
    [No Abstract]   [Full Text] [Related]  

  • 28. Tolerability of cyclooxygenase 2 inhibitors and the advisability of oral challenge.
    Rodríguez M; Enrique E; Castello JV; de Mateo JA; Roca B; Malek T
    Ann Allergy Asthma Immunol; 2003 Dec; 91(6):589. PubMed ID: 14700447
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular events and COX-2 inhibitors.
    Fleming M
    JAMA; 2001 Dec; 286(22):2808; author reply 2811-2. PubMed ID: 11735742
    [No Abstract]   [Full Text] [Related]  

  • 30. Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer.
    Sharma RA
    QJM; 2002 May; 95(5):267-73. PubMed ID: 11978897
    [No Abstract]   [Full Text] [Related]  

  • 31. Summaries for patients. The cost-effectiveness of cyclooxygenase-2 inhibitors for treating chronic arthritis.
    Ann Intern Med; 2003 May; 138(10):I39. PubMed ID: 12755582
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the renal and cardiovascular safety of celecoxib and rofecoxib.
    Schoors D
    Clin Ther; 2002 Mar; 24(3):468-9; author reply 469-70. PubMed ID: 11952030
    [No Abstract]   [Full Text] [Related]  

  • 33. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
    Bannwarth B
    Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
    [No Abstract]   [Full Text] [Related]  

  • 34. COX-2-specific inhibition: implications for clinical practice.
    Pascucci RA
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S18-22. PubMed ID: 10643177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The coxibs, third generation anti-inflammatories].
    Sternon J
    Rev Med Brux; 2001 Apr; 22(2):100-5. PubMed ID: 11388024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract]   [Full Text] [Related]  

  • 38. [Coxibs: cyclooxygenase-2 inhibitors].
    Turnheim K
    Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
    [No Abstract]   [Full Text] [Related]  

  • 40. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.